Living with Atopic Dermatitis: Effects beyond the skin’s surface
Head of Living With, Mariel Metcalfe, discusses the nature of Atopic Dermatitis and some key findings from a recent study conducted in Europe
Earlier this year, we published the report “Living with Atopic Dermatitis (AD) EU”, based on primary market research, which reveals key insights and unmet needs from the AD adult and paediatric patient perspective and treatment journey. In December 2017, we published a US report, which is also available to purchase.
Research Partnership launches new patient Living with Psoriatic Arthritis (PsA) 2019 EU report
Living with Psoriatic Arthritis is new a report conducted amongst 265 patients in France, Germany, Italy, Spain and UK. The report is based on the findings from 30-minute quantitative online and qualitative telephone interviews with patients. It will provide an update on the existing Living with PsA report published in 2016 and will be available to purchase in October 2019.
Living with rheumatoid arthritis: How social stigma, unemployment and the rise of mental illness affects patient attitudes toward their disease in Japan
Rachel Arthurs explores differing social attitudes towards RA between patients living in Japan and patients in Europe and Canada.
In recent months, Research Partnership’s Mariel Metcalfe alongside her Living With team have been conducting an in-depth multi-country study into the experiences of those living with rheumatoid arthritis. The study was carried out amongst patients in Europe, Canada and Japan to gain insights into the ways in which patients react to their diagnosis, manage their treatment and the possible support they hope to see in the future. An interesting trend that emerged during the course of the research was the differing social attitudes towards illness between patients living in Japan compared to those in Europe and Canada. Japanese patient’s daily lives are impacted differently to those in other countries, possibly due to pre-existing stigmas and social attitudes. In this article, we examine these differences, consider why they might occur and propose how we can use this understanding to improve global treatment solutions and marketing of existing and pipeline pharmaceuticals.
Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports
Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients in France, Germany, Italy, Spain and UK, while the AS US report is based on a study of 136 patients. The Living with nr-AxSpA report comprises of interviews with a total of 78 patients in the 5EU and the US. All of the studies consist of 30-minute quantitative online interviews and for the AS studies 30 minute qualitative tele-depth interviews. The reports are available to purchase in the following formats: AS (5EU), AS (US) and nr-AxSpA (5EU & US).
Research Partnership publishes new patient Living with Non-alcoholic Steatohepatitis (NASH) EU report
Living with Non-alcoholic Steatohepatitis (NASH) EU is a study conducted amongst 275 adults with NASH / NAFLD in France, Germany, Italy, Spain and UK. The report consists of 30-minute quantitative online and qualitative telephone interviews with patients. The report, which is now available for purchase, enables pharmaceutical companies developing products in this disease area to gain a deeper understanding of how patients come to be diagnosed with NASH, how it impacts their day-to-day lives and what their attitudes and perceptions are towards the management of their condition.